Results 81 to 90 of about 204,961 (215)

Chronic Disease Diagnoses Using Behavioral Data [PDF]

arXiv
Early detection of chronic diseases is beneficial to healthcare by providing a golden opportunity for timely interventions. Although numerous prior studies have successfully used machine learning (ML) models for disease diagnoses, they highly rely on medical data, which are scarce for most patients in the early stage of the chronic diseases.
arxiv  

Ultrasound-Coupled Microdroplet Laser Chip for High-Throughput Hyperlipidemia Screening [PDF]

arXiv
The mechanical properties of biological fluids can serve as early indicators of disease, offering valuable insights into complex physiological and pathological processes. However, the existing technologies can hardly support high throughput measurement, which hinders their broad applications in disease diagnosis. Here, we propose the ultrasound-coupled
arxiv  

The effects of hyperlipidemia on rotator cuff diseases: a systematic review

Journal of Orthopaedic Surgery and Research, 2018
BackgroundRotator cuff disease is a common condition that causes shoulder pain and functional disability. Recent studies suggested that hyperlipidemia might be associated with the development of rotator cuff disease.
Yang Yang, Jin Qu
semanticscholar   +1 more source

Anti-hyperlipidemia of garlic by reducing the level of total cholesterol and low-density lipoprotein

Medicine, 2018
Background: This study aimed to understand the impact of garlic on improving blood lipids using a meta-analysis. Methods: A literature search of the PubMed, EMBASE, and Cochrane Library databases was performed using keywords such as “garlic” and ...
Yue-e Sun, Wei-dong Wang, J. Qin
semanticscholar   +1 more source

High dose simvastatin and adverse muscle effects

Universa Medicina, 2016
High blood cholesterol, or hyperlipidemia, is a cardiovascular risk factor. Surveys have demonstrated that 35.6% of adults in the United States suffer from hyperlipidemia.(1) Currently there are various therapeutic regimens available for hyperlipidemia ...
Yenny Yenny
doaj   +1 more source

Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes

Lipids in Health and Disease, 2018
BackgroundThis study was to explore the effect of hyperlipidemia on the incidence of cardio-cerebrovascular diseases in patients with type 2 diabetes.MethodsThree hundred ninety five patients with type 2 diabetes in our hospital from January 2012 to ...
Dabei Fan, Li Li, Zhizhen Li, Ying Zhang, Xiaojun Ma, Lina Wu, G. Qin   +6 more
semanticscholar   +1 more source

Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia

Journal of Lipid Research, 2002
Atorvastatin, a synthetic HMG-CoA reductase inhibitor used for the treatment of hyperlipidemia and the prevention of coronary artery disease, significantly lowers plasma cholesterol and low-density lipoprotein cholesterol (LDL-C) levels.
Jeffrey S. Cohn, Michel Tremblay, Rami Batal, Hélène Jacques, Lyne Veilleux, Claudia Rodriguez, P.Hugh R. Barrett, Denise Dubreuil, Madeleine Roy, Lise Bernier, Orval Mamer, Jean Davignon   +11 more
doaj  

Propolis supplementation can reduce serum level of interleukin-6, C-reactive protein, and tumor necrosis factor-α: an updated systematic review and dose-response meta-analysis on randomized clinical trials

Journal of Health, Population and Nutrition
Background New evidence suggested that propolis might reduce serum levels of inflammatory mediators; therefore, in this study we aimed to prove the potential effect of propolis on serum levels of interleukin-6 (IL-6), C-reactive protein (CRP), and tumor ...
Ali Gholami, Negar Dinarvand, Mitra Hariri   +2 more
doaj   +1 more source

Overexpression of apoC-I in apoE-null mice

Journal of Lipid Research, 2002
Apolipoprotein C-I (apoC22222222246) has been proposed to act primarily via interference with apoE-mediated lipoprotein uptake. To define actions of apoC-I that are independent of apoE, we crossed a moderately overexpressing human apoC-I transgenic ...
Karin Conde-Knape, André Bensadoun, Joan H. Sobel, Jeffrey S. Cohn, Neil S. Shachter   +4 more
doaj  

Comparison of atherogenic indices for predicting the risk of metabolic syndrome in Southwest Iran: results from the Hoveyzeh Cohort Study (HCS)

Diabetology & Metabolic Syndrome
Background Metabolic syndrome (MetS) is a cluster of risk factors related to diabetes and cardiovascular disease (CVD). Given that early identification of MetS might decrease CVD risk, it is imperative to establish a simple and cost-effective method to ...
Hossein Babaahmadi‐Rezaei, Maedeh Raeisizadeh, Vahid Zarezade, Kourosh Noemani, Ahmad Mashkournia, Hossein Ghaderi-Zefrehi   +5 more
doaj   +1 more source